Why Documentation Errors Continue to Delay Medical Device Product Release

A device is manufactured, testing is complete, and the production run has finished on schedule. And yet, the product cannot ship.

For many medical device quality leaders, this is not an exception; it is a pattern. Finished devices sit in quarantine while QA teams track down missing signatures, reconcile disconnected records, and investigate discrepancies that should never have reached final review. Whether organizations refer to them as Device History Records (DHRs), eDHRs, or production records maintained within a Medical Device File (MDF), complete manufacturing documentation remains essential for release readiness under both legacy QSR and current QMSR expectations.

In highly regulated medical device environments, product release depends on more than successful manufacturing. Organizations must also demonstrate complete traceability, documented process adherence, and a fully reviewable Device History Record (DHR). When documentation is incomplete, release decisions stall regardless of production performance.

That is a documentation problem. And most organizations keep solving it the wrong way.

What Documentation Errors Are Blocking Medical Device Release?

Before any lot moves to distribution, the quality unit must verify a complete evidentiary chain. Device History Records (DHRs), now commonly mapped to Medical Device File (MDF) record requirements under FDA's QMSR framework, must confirm every significant manufacturing step: inspections, traceability, approvals, e-signatures, deviations, and acceptance criteria.

Beyond delaying release, documentation gaps can create challenges during audits, investigations, complaint reviews, and field actions, where manufacturers must demonstrate complete traceability and product history.

When that chain has gaps, review stops. Release waits.

The most common errors that trigger holds include:

• Missing operator signatures on critical steps
• Blank process parameter fields
• Corrections that raise data integrity questions
• Deviations recorded without investigation references
• Supporting records (calibration certificates, material data, inspection logs) that are absent or expired
• Incomplete traceability between materials, components, operators, and manufacturing activities

FDA’s FY2024 inspection dataset recorded a combined 95 medical device observation instances under 21 CFR 820.184 relating to inadequate DHR procedures, DHR maintenance, and DHR content.

Why Do the Same Errors Keep Recurring?

Documentation problems trace back to predictable structural causes, not individual operator failures.

In many manufacturing environments, production information is still documented retrospectively or transferred between systems after execution is complete. Operators may perform work in one system and document it elsewhere later, increasing the risk of omissions, transcription errors, and incomplete records.

Data lives across too many systems. DHR data frequently spans paper travelers, spreadsheets, ERP platforms, and standalone inspection systems. Quality reviewers spend hours reconciling information before they can determine whether a batch is releasable.

Even organizations that have digitized portions of batch execution often maintain information across ERP systems, spreadsheets, inspection records, training systems, and paper-based supporting documents. Every manual handoff creates another opportunity for documentation errors to enter the DHR/production records.

Training and authorization are not enforced at the step level. When no system-level control prevents an undertrained operator from starting a critical step, the error surfaces only during QA review, not before.

As a result, documentation issues are often discovered during batch review rather than prevented at the point of execution.

In one medical device manufacturing case documented by McKinsey, paper-based DHRs containing thousands of quality data points created nearly 100 opportunities for documentation errors every day.

What Does Documentation Failure Truly Cost?

The impact of documentation-related delays rarely stays within the quality department.

FDA’s FY2024 dataset also recorded 59 medical device observation instances for inadequate CAPA documentation under 21 CFR 820.100(b).

For quality leaders accountable for both compliance posture and operational performance, these numbers are difficult to absorb, especially when the root cause is structural and preventable.

Why Hasn't Going Digital Solved It?

Many manufacturers invested in Electronic Batch Record systems expecting paperless to mean error-free. For most, it has not.

Legacy EBR solutions replace paper with electronic forms while leaving core processes unchanged. Operators still document steps after the fact. Manufacturing and quality systems continue operating independently, creating duplicate data entry and fragmented records.

Many first-generation EBR implementations focus primarily on digitizing forms rather than controlling execution. While electronic records improve accessibility, they do not always enforce process controls, validate data in real time, verify operator authorization, or connect manufacturing activities with quality processes.

The fundamental issue is not the format of the record. It is when and how data is captured, and whether the system actively prevents errors or simply records them.

How Review by Exception Changes Batch Release

Traditionally, QA teams review batch documentation page by page, searching for missing signatures, incomplete fields, deviations, and documentation discrepancies before a product can be released.

When documentation controls are embedded during execution, many of these issues can be identified immediately as they occur. Rather than reviewing every completed activity, quality teams can focus on exceptions that require attention.

Review-by-exception approaches help manufacturers:

• Reduce manual batch review effort
• Improve consistency of documentation processes
• Accelerate batch disposition decisions
• Enable QA teams to focus on risks rather than paperwork

For many manufacturers, review by exception is one of the most effective ways to shorten release timelines while maintaining compliance and traceability.

How Can Batch Records Be Built During Execution, Not Reconstructed After?

BatchQuest, ComplianceQuest’s next-generation Electronic Batch Record Solution, moves manufacturers beyond record digitization to controlled, real-time execution. BatchQuest helps medical device manufacturers move beyond simple record digitization by embedding execution controls directly into manufacturing workflows.

This transforms manufacturing from a reactive, documentation-driven process into a controlled system where errors are prevented, not corrected later.

Rather than treating the batch record as a document completed after production, BatchQuest treats it as a live guided execution environment:

• Guided operator workflows enforce sequencing, role-based access, and embedded instructions for right-first-time execution
• In-process parameter validation captures data with guardrails such as range checks, type validation, and automated error prevention
• Training and authorization enforcement verifies operator readiness before each step begins
• Integrated quality management links execution directly to non-conformance, training, and change control workflows, so deviations are traceable from the moment they occur

The result: a complete, traceable DHR (or equivalent production record structure within an MDF-based QMSR framework) that is continuously built throughout execution rather than reconstructed during final review.

Impact Area	Consequence
Inventory	Holds disrupt downstream schedules, especially for short shelf-life products
QA Capacity	Teams chase paperwork instead of driving improvement
Customer Commitments	Delayed release means delayed shipment
Regulatory Standing	Repeat findings elevate risk at every subsequent inspection
Revenue Realization	Products cannot be shipped or recognized as available inventory until release is complete
Supply Continuity	Documentation-related release delays increase the risk of customer delivery delays and backorders
Financial Impact	McKinsey estimates that remediation activities including investigations, CAPAs, complaints, medical device reports, and field actions represent 0.4–0.7% of annual sales for medical device companies.

Key Takeaways

• Documentation errors at product release are structural, not random, and trace directly to how and when batch records are built
• The most common blockers (missing signatures, blank fields, non-compliant corrections) are preventable with guided, real-time execution
• Digitizing records without changing the execution process shifts errors from paper to screen. It does not eliminate them.
• Recurring documentation findings carry cumulative regulatory consequences that affect every subsequent inspection
• Connecting execution to QMS workflows ensures deviations are captured, documented, and actioned at the moment they occur

Frequently Asked Questions